Performance analysis of Curanex Pharmaceuticals (CURX)
Annual Return
Since Aug 26, 2025, CURX has had an average annual return of -96.43%, underperforming the benchmark SPY, which returned +18.29% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.05% | -91.78% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.07% | +39.13% | +13.57% | -18.47% | -20.25% | -20.19% | -24.09% | -39.05% | |||||
| 2025 | +39.30% | -87.14% | -5.92% | -28.07% | -32.18% | -91.78% |
Drawdown analysis of Curanex Pharmaceuticals (CURX)
The maximum drawdown for the CURX was -97.80%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current CURX drawdown is -97.80%.
Since Aug 26, 2025 CURX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.80% | Sep 16, 2025 | 210 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |
| -1.92% | Sep 12, 2025 | 1 | Sep 15, 2025 | 1 | Sep 16, 2025 | 2 |
| -1.77% | Sep 9, 2025 | 1 | Sep 10, 2025 | 1 | Sep 11, 2025 | 2 |